Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is SGLT2 Inhibitors a Better Prophylactic Agent Against Post-contrast Acute Kidney Injury in Diabetic Kidney Disease? A Multicenter Prospective Randomized Controlled Study

NCT04853615 is registered in ClinicalTrials.gov with Fayoum University as lead sponsor.

NCT NCT04853615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04853615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is SGLT2 Inhibitors a Better Prophylactic Agent Against Post-contrast Acute Kidney Injury in Diabetic Kidney Disease? A Multicenter Prospective Randomized Controlled Study
Lead sponsor
Fayoum University
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2021
Completion date
August 1, 2024
Enrollment
800 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sglt2i kideny protection against contrast in diabetic kidney